CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

CURE Pharmaceutical announced today that it has signed an exclusive licensing agreement… The post CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery appeared first on The Daily Marijuana Observer.

Excerpt only …
READ MORE BELOW
Source : MJ OBSERVER
Link to original : CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.